SapVax Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

SapVax General Information

Description

Developer of peptide vaccine immunotherapies intended to treat cancer. The company's technology utilizes a proprietary chemistry platform and cysteine lipidation to produce fully-synthetic, self-adjuvating cancer vaccines, enabling the stimulation of cancer-killing T cells in patients with NY-ESO-1-positive tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 232 Rama V Road
  • Dusit
  • Bangkok
  • Thailand
+66 02
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Vertical(s)
Corporate Office
  • 232 Rama V Road
  • Dusit
  • Bangkok
  • Thailand
+66 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SapVax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 11-Apr-2023 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 14-Jan-2019 Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2016 Completed Pre-Clinical Trials
To view SapVax’s complete valuation and funding history, request access »

SapVax Patents

SapVax Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200347108-A1 Peptide conjugates incorporating urea elements and their use as vaccines Inactive 02-May-2019

SapVax Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SapVax Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Auckland UniServices Corporate Venture Capital Minority
To view SapVax’s complete investors history, request access »

SapVax FAQs

  • When was SapVax founded?

    SapVax was founded in 2016.

  • Where is SapVax headquartered?

    SapVax is headquartered in Bangkok, Thailand.

  • What is the size of SapVax?

    SapVax has 4 total employees.

  • What industry is SapVax in?

    SapVax’s primary industry is Drug Discovery.

  • Is SapVax a private or public company?

    SapVax is a Private company.

  • What is SapVax’s current revenue?

    The current revenue for SapVax is .

  • How much funding has SapVax raised over time?

    SapVax has raised $3.25M.

  • Who are SapVax’s investors?

    Auckland UniServices has invested in SapVax.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process